Welcome to Launch Code, an executive briefing designed to surface the hidden risks that derail healthcare launches. Each edition isolates one risk and equips leaders with decision infrastructure to reduce exposure, accelerate adoption, and protect valuation before reversing course becomes costly.
Last month, we exposed The Product Adoption Lie: Why Better Doesn’t Win.
This month, we’re holding up the mirror.
Most life-sciences CEOs don’t need another reminder that adoption is unpredictable. They need a system to reveal why.
That’s the purpose of the Product Adoption Lie Diagnostic—a short, evidence-based diagnostic that shows where belief fractures between your internal conviction and the market’s behavior.
The findings are rarely comfortable. But they’re always clarifying.
In this briefing:
- Most launch failures can be traced to missing readiness.
- Is your team ready? Is your market ready?
- What belief breakdown looks like in practice.
- Until you know where belief breaks, every forecast is a bet.
- The commercial due diligence you can’t skip.
- Take action
Every launch plan tracks what can be modeled—budgets, timelines, manufacturing runs, and revenue forecasts. But the real failure variable hides where spreadsheets can’t see it: belief readiness.
Consider the evidence:
Different data, same conclusion: organizations are extraordinarily confident in things they can’t actually see—market belief, stakeholder behavior, adoption momentum.
The gap isn’t operational. It’s optical. You can’t fix what you don’t see.
Belief is invisible until it’s missing.
The Product Adoption Lie Map gives CEOs a visual language for misalignment—four predictable places launches fail.
Most companies land in Internal Mirage or Alignment Gap. Inside the walls, momentum feels real. Outside, the market is still unmoved.
That’s not an execution issue. It’s a belief-engineering issue.
Here’s what belief breakdown looks like in practice.
J&J’s Sedasys system was pitched as the future of anesthesia—a computer-assisted sedation device that could replace an anesthesiologist for routine endoscopic procedures. It worked. It cut costs by nearly 90%.
But the market never accepted it. Professional societies fought it. Hospitals hesitated. Liability fears multiplied. To survive, J&J narrowed indications to low-risk cases requiring an anesthesiologist on call, erasing the savings that made it revolutionary.
The device failed to gain traction and was discontinued only a year into its launch.
Innovation without market alignment can lead to resistance, not adoption. Even the most promising technologies can falter if they don’t fit into the ecosystem they aim to transform.
Disruption without belief isn’t progress—it’s provocation.
The Product Adoption Lie Diagnostic functions as a commercial-readiness checkpoint—an explicit pause to validate belief before capital, credibility, or momentum are committed.
It surfaces the one variable traditional launch planning can’t model: whether the market is actually prepared to change.
It helps leadership teams answer three questions:
This isn’t about messaging or execution. It’s about confirming readiness before forecasts harden and decisions become irreversible.
Testing belief is commercial due diligence.
After running the diagnostic with dozens of leadership teams, one pattern keeps surfacing: Most companies discover they’re not as ready as they think.
Some score high on internal conviction but low on market conditioning: the Internal Mirage. Others show cross-functional drift: the Alignment Gap.
Both create the illusion of success—until the numbers tell a different story.
Recognizing your readiness state isn’t a verdict. It’s insurance.
Until you know where belief breaks, every forecast is a bet.
If your diagnostic exposes belief gaps, the next step is validation. The Pivotal Commercial Design Review (PCDR) quantifies your exposure before capital is committed—a commercial due-diligence step that safeguards your launch.
The diagnostic gives you the signal; the PCDR turns that signal into a plan.
Because the cost of correction is a gamble no responsible leader can afford to take.
See where belief breaks down between internal conviction and market readiness—before critical decisions are locked.
A one-page executive summary of the Product Adoption Lie Map and the forces of market resistance that stall launches. Includes key takeaways and discussion questions to help your team identify and reduce resistance before you scale.
Get the Boardroom Brief